SBIR/STTR Research Award
IGF OT IGF SBIR TOPIC PHASE II NOVEL BIOABSORBABLE FLEXIBLE POLYMERIC STENT FOR PEDIATRIC CARDIOLOGY
Award amount
$512,507Program and phase
SBIR · Phase IIAward year
2015Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Lyra Therapeutics, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- DK48JGAVNMJ1
- Solicitation number
- Not reported
- Topic code
- ODHLBI
Research abstract
Not Available
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- SBIR TOPIC 096:Novel Biodegradable Stents for Neonatal Aortic Coarctation
- Novel Bioabsorbable, Flexible Polymeric Stent for Pulmonary Artery Stenosis
- IGF OT IGF SBIR TOPIC THE DEVELOPMENT LEADING TO THE COMMERCIALIZATION OF A BIORESORBABLE STENTS BRS FOR THE TREATMENT OF COARCTATION OF THE AORTA IN NEONATES CAN
Research funding history
4 SBIR/STTR records share this UEI (2015–2018). Reported award amounts total $6,768,961. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Health and Human Services